Stock BIIB34 BIOGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Biogen Inc. Sao Paulo

Equities

BIIB34

BRBIIBBDR001

Delayed Sao Paulo
Other stock markets
 11:23:53 2024-07-05 EDT 		5-day change 1st Jan Change
206 BRL -2.76% Intraday chart for Biogen Inc. -4.15% +0.39%
07-02 US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments MT
07-02 Equity Markets Mostly Rise Intraday After Fed Chair Powell's Comments MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BIIB Kessler Topaz Meltzer & Check, LLP Reminds Biogen Inc. (BIIB) Investors of Securities Fraud Class Action Lawsuit Filed On the Behalf
PR
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
PR
July 22, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against BIIB
PR
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
PR
Biogen Inc. Sued for Securities Law Violations - Contact the Schall Law Firm to Discuss Your Legal Rights BIIB
PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIB
PR
Biogen Completes Acquisition of Human Immunology Biosciences
GL
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc.(BIIB) Shareholders
PR
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Biogen Inc. (BIIB)
PR
BIIB LAWSUIT ALERT: The Gross Law Firm Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GL
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
PR
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
PR
Shareholders of Biogen Inc. Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB
PR
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
PR
BIIB Investors Have Opportunity to lead Biogen Inc. Securities Fraud Lawsuit
PR
Class Action Filed Against Biogen Inc. (BIIB) Seeking Recovery for Investors - Contact The Gross Law Firm
PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIB
PR
TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union
GL
Securities Fraud Class Action Lawsuit Was Filed Against Biogen Inc. (BIIB) - Contact Kessler Topaz Meltzer & Check, LLP
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIIB Stock
  4. BIIB34 Stock
  5. News Biogen Inc.
  6. Press Releases